Apnimed, Inc. (APMD)
NASDAQ: APMD · Real-Time Price · USD
28.55
-3.48 (-10.86%)
Aug 20, 2026, 4:00 PM EDT - Market closed
Apnimed Employees
Apnimed had 65 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
65
Change
n/a
Growth
n/a
Revenue / Employee
$1,848,462
Profits / Employee
-$489,631
Market Cap
1.58B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 65 | 0 | - |
| Dec 31, 2025 | 65 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Novavax | 749 |
| Immatics | 678 |
| MannKind | 592 |
| MeiraGTx Holdings | 393 |
| Omeros | 175 |
| Monte Rosa Therapeutics | 173 |
| Alpha Tau Medical | 121 |
| Alto Neuroscience | 68 |
APMD News
- 17 days ago - Apnimed Announces Closing of Upsized Initial Public Offering, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 20 days ago - Apnimed opens at $22.00, IPO priced at $16.00 - TheFly
- 20 days ago - Apnimed 12M share IPO priced at $16.00 - TheFly
- 24 days ago - Sleep apnea pill developer Apnimed targets $608 million valuation in US IPO - Reuters
- 5 weeks ago - Sleep apnea pill maker Apnimed files for US IPO as biotech market revives - Reuters
- 5 weeks ago - Apnimed IPO Registration Document (S-1) - SEC